Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decision rule based multiplicity adjustment strategy.

Xun Chen1, Tom Capizzi, Bruce Binkowitz

  • 1Clinical Biostatistics, Sanofi-Aventis, Bridgewater, NJ 08807, USA. xun.chen@sanofi-aventis.com

Clinical Trials (London, England)
|December 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bayesian evaluation for latent variable models: A tutorial on computing information criteria and bayes factors with the r package bleval.

Psychological methods·2026
Same author

EBF1 Deficiency Drives Prostate Cancer Progression by Interfering with the Transcriptional Regulation of <i>ITPR1</i>.

Oncology research·2026
Same author

Alteration in cerebral cortex thickness and structural covariance networks in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

Frontiers in neurology·2026
Same author

Research on noise reduction of annular axial cooling fan blade with perforated structure.

Scientific reports·2026
Same author

Epidemiological characteristics of serum small dense low-density lipoprotein cholesterol: From 2017 to 2019 in Chengdu adults, China.

Medicine·2026
Same author

SMPD1 modulates malignant progress of osteosarcoma through ferroptosis pathway.

Tissue & cell·2026
Same journal

A statistical evaluation of decision-making methods and the efficiency of Bayesian multi-arm multi-stage trials.

Clinical trials (London, England)·2026
Same journal

Accounting for non-adherence: A re-analysis of the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results trial.

Clinical trials (London, England)·2026
Same journal

Phase I design for partially ordered groups with late-onset toxicity.

Clinical trials (London, England)·2026
Same journal

Trial informed consent forms, the Declaration of Helsinki and the SPIRIT 2025 statement.

Clinical trials (London, England)·2026
Same journal

17th Annual University of Pennsylvania Conference on statistical issues in clinical trials - Covariate adjustment in randomized clinical trials: New methods and applications (Morning panel discussion).

Clinical trials (London, England)·2026
Same journal

17th Annual University of Pennsylvania Conference on statistical issues in clinical trials - Covariate adjustment in randomized clinical trials: New methods and applications (Afternoon panel discussion).

Clinical trials (London, England)·2026
See all related articles

This study introduces a new decision rule for multiplicity adjustment in clinical trials. This strategy controls Type I error rates within hypothesis families, reducing controversy in statistical analysis.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Inference

Background:

  • Determining the need for multiplicity adjustment in clinical trials can be complex and lead to controversy.
  • Existing methods may not adequately address the logical relationships between multiple hypotheses.
  • Controlling the Type I error rate is crucial for the validity of clinical trial results.

Purpose of the Study:

  • To propose a novel decision rule-based multiplicity adjustment strategy.
  • To link hypotheses by their logical relationships and group them into families.
  • To maintain strong control of the Type I error rate within each defined family.

Main Methods:

  • Development of a multiplicity adjustment strategy based on a predefined clinical trial decision rule.

Related Experiment Videos

  • Grouping of multiple hypotheses into distinct families according to logical relationships.
  • Application of the proposed strategy to a real-world clinical trial dataset.

    • Main Results:

    • The proposed strategy effectively minimizes potential controversies in multiplicity adjustment.
    • Demonstrated application to a raloxifene clinical trial shows practical utility.
    • Maintained strong control of Type I error rates within hypothesis families.

    Conclusions:

    • The decision rule-based multiplicity adjustment strategy offers a robust approach to managing multiple comparisons.
    • This method enhances the reliability and interpretability of clinical trial findings.
    • The strategy provides a structured framework for hypothesis testing in complex trial designs.